PTK2 and breast carcinoma: Inhibition of FAK has shown synergistic apoptotic effects with EGF receptor blockade in breast cancer [44], suggesting that disrupting phospholipid synthesis via FASN inhibition impairs EGFR localization, attenuates FAK-associated signaling, and induces apoptosis.